OVER the past few years, the subtle marketing tactics of companies selling pharmaceuticals and medical devices have come under scrutiny as never before. There are good reasons for this: it has become common practice for them to court doctors who prescribe their products and employ experts in the biomedical community to speak and advise on their behalf.
This week Â鶹´«Ã½ looks at another area where the industry may be wielding inappropriate influence: organisations that represent patients. Our investigation found that while donations from drugs companies make up less than 10 per cent of most patient groups’ budgets, some…
